U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 531 - 540 of 1059 results

mixture
Status:
Possibly Marketed Outside US
Source:
NCT01683565: Phase 4 Interventional Completed Preterm Birth
(2012)
Source URL:

Class:
MIXTURE

mixture
Status:
Possibly Marketed Outside US
Source:
EPRINEX by Merck
Source URL:

Class:
MIXTURE



Eprinomectin is a mixture of two homologues, eprinomectin B1a (90%) and eprinomectin B1b (10%). The drug is indicated for the treatment of gastrointestinal roundworms in cattle. Eprinomectin acts by binding to glutamate-gated chloride ion channels that leads to paralysis and death of the parasite.
mixture
Status:
Possibly Marketed Outside US
Source:
UK NHS:Hyetellose
Source URL:

Class:
MIXTURE

mixture
Status:
Possibly Marketed Outside US
First approved in 1978

Class:
MIXTURE